Clinuvel Pharmaceuticals Limited income statement CUVL
In fiscal 2026, which ended Jun 30, 2026, Clinuvel Pharmaceuticals Limited reported revenue of $64.3 million. Net income was $23.2 million, a profit margin of 36.0%. Operating income came to $27.9 million, an operating margin of 43.4%. Diluted earnings per share were $0.46.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
|---|---|
| Revenue |
64
|
| Cost of revenue |
11
|
| Gross profit |
53
|
| Research and development |
12
|
| Selling, general and administrative |
7
|
| Operating income |
28
|
| Pretax income |
33
|
| Income tax |
10
|
| Net income |
23
|
| Basic EPS |
0.46
|
| Diluted EPS |
0.46
|
| Weighted average shares, basic |
50
|
| Weighted average shares, diluted |
51
|
| Other measures | |
| Depreciation and amortization |
0
|
| EBITDA |
28
|
| Margins | |
| Gross margin |
82.93%
|
| Operating margin |
43.41%
|
| Pretax margin |
50.87%
|
| Profit margin |
36.04%
|
| EBITDA margin |
44.02%
|
| Effective tax rate |
29.15%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- American Depositary Receipts (SIC 8880)
- Listed as
- CUVL (Nasdaq), CLVLF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1290877
- Former names
- EpiTan LTD (until Mar 20, 2006)
Other American Depositary Receipts companies
- Kongsberg Gruppen ASA/ADR KBGGY
- Sumitomo Electric Industries LTD/ADR/ SMTOY
- MTN Group LTD/ADR MTNOY
- Daiwa Securities Group Inc. DSEEY
- Yara International ASA YARIY
- Weir Group PLC/ADR WEGRY
- Pandora A/S / ADR PNDRY
- Vibra Energia S.A./ADR VBREY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.